A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT01872689 · COMPLETED

Trial details

NCT number: NCT01872689
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2013-10-13
Primary completion: 2017-07-28
Enrollment: 505

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.